Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
29.10
-0.68 (-2.28%)
At close: Mar 28, 2025, 4:00 PM
29.50
+0.40 (1.37%)
After-hours: Mar 28, 2025, 7:45 PM EDT
Janux Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$91.25
Upside
+213.57%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +140.55% | Mar 3, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $62 → $41 | Hold | Maintains | $62 → $41 | +40.89% | Feb 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +587.29% | Dec 11, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $42 → $62 | Hold | Maintains | $42 → $62 | +113.06% | Dec 4, 2024 |
| Stifel | Stifel | Strong Buy Maintains $70 → $115 | Strong Buy | Maintains | $70 → $115 | +295.19% | Dec 3, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $79 → $91 | Buy | Maintains | $79 → $91 | +212.71% | Dec 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $63 → $70 | Strong Buy | Maintains | $63 → $70 | +140.55% | Dec 3, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $79 | Buy | Initiates | $79 | +171.48% | Nov 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +116.49% | Nov 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +243.64% | Nov 7, 2024 |
| UBS | UBS | Strong Buy Initiates $69 | Strong Buy | Initiates | $69 | +137.11% | Oct 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +243.64% | Sep 16, 2024 |
| Stifel | Stifel | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +140.55% | Sep 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +116.49% | Aug 19, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $47 → $42 | Hold | Maintains | $47 → $42 | +44.33% | Aug 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +243.64% | Aug 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.